White House, AstraZeneca to Deliver Lower US Drug Prices
The White House-AstraZeneca deal aims to lower costs for state Medicaid programs and patients nationwide.
The White House announced a new agreement with AstraZeneca to align U.S. drug prices with those of other developed nations under the administration’s most-favored-nation, or MFN, pricing initiative.
The deal aims to lower costs for state Medicaid programs and patients nationwide while strengthening pharmaceutical supply chains, the White House said.
- Bevespi Aerosphere
- Breztri Aerosphere
- Airsupra
These inhaler products treat asthma and chronic obstructive pulmonary disease, known as COPD.
No additional quotes available.
Author summary: AstraZeneca deal lowers US drug prices.
More News
- EU Updates Age Verification Standards for Minors
- TBA, Appraisal, Reverse Mortgage Tools; STRATMOR on AI and Competition; Can the CFPB be Willed Away?
- Manchester United’s stance on Kobbie Mainoo leaving Old Trafford in January revealed
- Borrower Monitoring, AI Processing, DPA, Verification Tools; Events and Training; Robots Will do What?
- Fabrizio Romano has terrible news for Tottenham midfielder